VHAG in Treating R/R T-ALL/LBL

NCT06742463 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Acute T Lymphpblastic Leukemia/Lymphoma

Interventions

DRUG: Venetoclax
DRUG: homoharringtonine
DRUG: Cytarabine (Ara-C)
DRUG: G-CSF

Sponsor

First Affiliated Hospital of Zhejiang University